Switching from branded alendronate or risedronate to generic alendronate: Effect on persistence with bisphosphonate therapy in Germany

被引：0
|
作者：
Ziller, V. [1 ]
Schuessel, K.
Czeche, S.
Franzmann, A.
Kloeckner, D.
Quinzler, R.
Schulz, M. [2 ]
Moehrke, W. [3 ]
Hadji, P. [1 ]
机构：
[1] Univ Hosp Giessen & Marburg, Dept Gynecol, Marburg, Germany
[2] DAPI Verein Deutsch Arzneiprufungsinst eV, Eschborn, Germany
[3] Procter & Gamble Pharmaceut, Schwalbach A Ts, Germany
来源：
BONE | 2009年 / 44卷 / 02期
关键词：
D O I：
10.1016/j.bone.2009.03.423
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S449 / S450
页数：2
相关论文
共 50 条
  • [21] Persistence with weekly alendronate therapy among postmenopausal women
    Lo, J. C.
    Pressman, A. R.
    Omar, M. A.
    Ettinger, B.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 (06) : 922 - 928
  • [22] The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro
    Farese, JP
    Ashton, J
    Milner, R
    Ambrose, LL
    Van Gilder, J
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2004, 40 (3-4) : 113 - 117
  • [23] The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro
    James P. Farese
    Jenna Ashton
    Rowan Milner
    Linda-Lee Ambrose
    James van Gilder
    In Vitro Cellular & Developmental Biology - Animal, 2004, 40 : 113 - 117
  • [24] Effect of Risedronate and Alendronate Treatment on Femoral Bone Quality and Collagen Integrity
    Bagis, Selda
    Comelekoglu, Ulku
    Yalin, Serap
    Yilmaz, Nejat
    Ogenler, Oya
    Yildiz, Altan
    Nayci, Ali
    ASIAN JOURNAL OF CHEMISTRY, 2009, 21 (02) : 1033 - 1041
  • [25] The effect of mandatory generic substitution on the safety of alendronate and patients' adherence
    Lai, Pauline Siew Mei
    Chua, Siew Siang
    Chong, Yah Huei
    Chan, Siew Pheng
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (08) : 1347 - 1355
  • [26] Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy
    R. Lindsay
    N. B. Watts
    J. L. Lange
    P. D. Delmas
    S. L. Silverman
    Osteoporosis International, 2013, 24 : 2345 - 2352
  • [27] Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy
    Lindsay, R.
    Watts, N. B.
    Lange, J. L.
    Delmas, P. D.
    Silverman, S. L.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (08) : 2345 - 2352
  • [28] Effects of Denosumab in Postmenopausal Women Transitioning from Alendronate Therapy in Comparison with Continued Alendronate
    Kendler, David L.
    Roux, Christian
    Benhamou, Claude Laurent
    Brown, Jacques P.
    Lillestol, Mike
    Siddhanti, Suresh
    Man, Hoi-Shen
    Martin, Javier San
    Bone, Henry G.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2566 - 2567
  • [29] Effect of alendronate therapy in children with osteogenesis imperfecta
    Vyskocil, V
    Pikner, R
    Kutílek, T
    JOINT BONE SPINE, 2005, 72 (05) : 416 - 423
  • [30] Switching from one generic alendronate to another - a common procedure in Poland in the years 2001-2005
    Franek, Edward
    Talalaj, Marek
    Wichrowska, Hanna
    Czerwienska, Beata
    Filip, Rafal
    Safranow, Krzysztof
    Marcinowska-Suchowierska, Ewa
    Wiecek, Andrzej
    ENDOKRYNOLOGIA POLSKA, 2011, 62 (01) : 14 - 17
12345